Presence of the full-length KIR2DS4 gene reduces the chance of rheumatoid arthritis patients to respond to methotrexate treatment

Edyta Majorczyk, Andrzej Pawlik, Daria Gendosz de Carrillo, Piotr Kuśnierczyk

BMC Musculoskeletal Disorders · 2014 · 14 citations · 27 references

DOIFull text

Open access

Abstract

Our results suggest that the response of RA patients with medium ESR values to MTX treatment may be dependent on the full-length KIR2DS4 gene.

References

27